+91 - 830 - 3146878
The efficacy study of herbomineral drug of LAS02 was evaluated in Lung cancer patients who admitted in Lucknow and Noida City of Lavanya Ayurvedic Hospital & Research Centre For Cancer and AIDS. The study was conducted after getting ethical clearance. Total 31 patients were enrolled in Lucknow and Noida city of Lavanaya hospital. These patients were suffering only from Lung cancer not any other diseases. All patients having medication ayuredic herbomineral drug of LAS02 for more than one month treatment. After obtaining prior consent form these patients, venous blood samples was collected from the subjects before and after treatment with herbomineral drug of LAS02 and measured the hematological and biochemical examinations along with Lung cancer biomarker and tumor size.
A percentage lavel reduction of tumor size (mm) 32.85% in Lung cancer 31 patients Lucknow and noida as compared to before treated patients (n=31) There was percentage lavel17.23% decreased ESR levels in patients after treatment with LAS02 more than one month as compared with before treatment. A percentage lavel reduction of hepatic enzymes (SGOT, SGPT, ALP and LDH ) in patients after treatment with drug.
The study was conducted after getting ethical clearance from Institutional human ethic committee. Total 31 cancer patients with age (30-80 years) were enrolled in two city of Lavanya Ayurvedic Hospital and Research Centre. These patients were only suffering from Lung cancer not from any organic diseases. After obtaining prior consent form, venous blood samples was collected from the subjects before (pre) and after treatment (post) with herbomineral drug of LAS02 under aseptic condition. The drug was given to these patients for two months. After collection of blood sample, serum and plasma were separated by centrifugation at 4000 rpm for 10 min. at room temperature for measurement of hematological, biochemical parameters along with CEA and CA 15.3 Biomaker and total tumor size (mm) in pre and post treated patients.
All hematological and biochemistry parameters Hemoglobin (Hb), alkaline phosphate (ALP), Serum glutamate oxaloacetate transminase (SGOT), Serum glutamate pyurvate transminase (SGPT) parameters were measured by fully automatic cell counter and clinical chemistry analyzer.
LDH activity was measured by kit according to protocol provided by supplier (Transasia biomedical) The activity was expressed as an IU/ml.
Levels of serum CEA and CA-15.3 (CALBIOTECH Diagnostics), was determined using a quantitative sandwich enzyme immunoassay according to manufacturer protocol.
Resulting data were expressed mean ± SD. Percentage parenthesis was observed between pre vs post treatment with LAS02 drug in lung cancer patients.
The percentage lavel 32.85% of total tumor size (mm) in patient post treated group in comparison to patient pre treated group. VIEW CHART
There were percentage lavel 85.40% and 51.66% of CEA and CA15.3 enzyme activities in patients post treated group in comparison to patient pre treated group. VIEW CHART
The percentage lavel of ESR was also found to be 17.23% decreased in the patients after treatment with LAS02 in comparison to pre treatment.
TThere were slightly increased Hb(%), hematocrit and RBC levels in patient treated group as compared with patient pre treated group. VIEW CHART
There were percentage lavel was fond to be 11.91% and 16.70% of LDH and ALP enzyme activities in patients post treated group in comparison to patient pre treated group. VIEW CHART
On the basis of these findings it is suggested that the herbomineral drug LAS02 is most effective medicine for prevention of Lung cancer diseases.
The purpose of this study was to evaluate the acute oral toxicity study of LAS02 in female Sprague Dawley rat model. [...]
The purpose of this study was to evaluate the maximum tolerated dose of LAS02 in Sprague dawley female rat. [...]
The aim of this study was to evaluate the maximum tolerated dose of LAS02 in female Sprague Dawley rat. [...]